Condition
Lung Neoplasm Malignant clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Lung Neoplasm Malignant clinical trials that are recruiting, at sites in 15 countries (most in China (3), Denmark (2), Greece (2)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 15Countries
Newest Lung Neoplasm Malignant clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Enhanced COPD care for people being checked for lung cancer | — | Vejle | Recruiting | Apr 22, 2026 |
| MK-1084 combined with other therapies for advanced non-squamous non-small cell lung cancer | Phase 1/2 | Clermont, Florida and 28 other locations | Recruiting | Dec 16, 2025 |
| Low-dose intestinal radiation plus immunotherapy for immune-resistant metastatic solid cancers | Phase 2 | Shantou, Guangdong | Recruiting | Jul 17, 2025 |
| Using advanced CT imaging to improve lung cancer diagnosis | — | Herlev, Capital Region | Recruiting | Jun 4, 2024 |
| Evaluating a new imaging technique for lung cancer diagnosis | — | New York, New York and 4 other locations | Recruiting | Oct 12, 2023 |
| Understanding response to stereotactic body radiotherapy in early-stage lung cancer | — | Milan, Italy and 1 other locations | Recruiting | Aug 3, 2023 |
| Combining sintilimab, bevacizumab, and chemotherapy for lung cancer treatment before surgery | — | Shanghai, Shanghai Municipality | Recruiting | Jul 22, 2021 |
All recruiting trials (7)
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
MK-1084 combined with other therapies for advanced non-squamous non-small cell lung cancer
This trial tests whether MK-1084 given with other anti-cancer drugs can shrink tumors in people with advanced or metastatic non-squamous NSCLC who have a KRAS G12C mutation and have progressed after prior platinum chemotherapy and PD-(L)1 therapy.
-
Low-dose intestinal radiation plus immunotherapy for immune-resistant metastatic solid cancers
This trial tests whether giving small doses of radiation to the intestine together with PD‑1/PD‑L1 immunotherapy can help people whose metastatic solid tumors have stopped responding to checkpoint inhibitors.
-
Using advanced CT imaging to improve lung cancer diagnosis
This study is testing a new type of CT scan to see if it can help doctors better diagnose lung cancer compared to regular CT and PET scans.
-
Evaluating a new imaging technique for lung cancer diagnosis
This study is testing a new imaging technique during lung procedures to see if it helps doctors diagnose lung cancer more accurately in patients with suspicious lung lesions.
-
Understanding response to stereotactic body radiotherapy in early-stage lung cancer
This study is trying to understand why some people with early-stage lung cancer respond better to a specific type of radiation treatment than others, to help improve future treatments.
-
Combining sintilimab, bevacizumab, and chemotherapy for lung cancer treatment before surgery
This study is testing a new treatment that combines two medications and chemotherapy before surgery to see if it helps people with advanced lung cancer.
Related topics
Quick answers
How many Lung Neoplasm Malignant clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in China (3 trials), Denmark (2 trials), Greece (2 trials), Italy (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.